These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21948603)

  • 1. [Early treatment of statins after acute coronary syndrome?].
    Hamm CW
    Dtsch Med Wochenschr; 2011 Sep; 136(39):1941. PubMed ID: 21948603
    [No Abstract]   [Full Text] [Related]  

  • 2. Statins for acute coronary syndrome.
    Vale N; Nordmann AJ; Schwartz GG; de Lemos J; Colivicchi F; den Hartog F; Ostadal P; Macin SM; Liem AH; Mills E; Bhatnagar N; Bucher HC; Briel M
    Cochrane Database Syst Rev; 2011 Jun; (6):CD006870. PubMed ID: 21678362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins for acute coronary syndrome.
    Vale N; Nordmann AJ; Schwartz GG; de Lemos J; Colivicchi F; den Hartog F; Ostadal P; Macin SM; Liem AH; Mills EJ; Bhatnagar N; Bucher HC; Briel M
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD006870. PubMed ID: 25178118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early administrations of statins after acute coronary syndrome].
    Linde JJ; Jensen GB
    Ugeskr Laeger; 2012 Jun; 174(26):1801-3. PubMed ID: 22735112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosuvastatin for cardiovascular prevention: too many uncertainties.
    Prescrire Int; 2009 Aug; 18(102):176. PubMed ID: 19746571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.
    Kones R
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):309-15. PubMed ID: 19460829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) trial.
    Murphy SA; Cannon CP; Wiviott SD; McCabe CH; Braunwald E
    J Am Coll Cardiol; 2009 Dec; 54(25):2358-62. PubMed ID: 20082923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease.
    Chan PS; Nallamothu BK; Gurm HS; Hayward RA; Vijan S
    Circulation; 2007 May; 115(18):2398-409. PubMed ID: 17452609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in cardiovascular disease: a comprehensive review.
    Mihos CG; Salas MJ; Santana O
    Cardiol Rev; 2010; 18(6):298-304. PubMed ID: 20926939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue ACE inhibitors for secondary prevention of cardiovascular disease in patients with preserved left ventricular function: a pooled meta-analysis of randomized placebo-controlled trials.
    Saha SA; Molnar J; Arora RR
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):192-204. PubMed ID: 17875946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early statin therapy in elderly patients presenting with acute coronary syndrome causing less heart failure.
    Saab FA; Petrina M; Kline-Rogers E; Fang J; Otten R; Mukherjee D; Eagle KA
    Indian Heart J; 2006; 58(4):321-4. PubMed ID: 19039148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of early high dose statins in acute coronary syndrome.
    Dougherty PJ; Arora RR
    Am J Ther; 2012 Sep; 19(5):369-76. PubMed ID: 22964560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical indicators for recurrent cardiovascular events in acute coronary syndrome patients treated with statins under routine practice in Thailand: an observational study.
    Chinwong D; Patumanond J; Chinwong S; Siriwattana K; Gunaparn S; Hall JJ; Phrommintikul A
    BMC Cardiovasc Disord; 2015 Jun; 15():55. PubMed ID: 26076586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Statins in acute coronary syndrome].
    Lama T A; Vega A J
    Rev Med Chil; 2008 Aug; 136(8):1083-5. PubMed ID: 18949196
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of statins in the prevention of heart failure after acute coronary syndrome.
    Kumar A; Cannon CP
    Heart Fail Clin; 2008 Apr; 4(2):129-39. PubMed ID: 18433693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Administration of statins during the acute phase of acute coronary syndrome].
    Ruiz-Bailén M
    Med Intensiva; 2010; 34(1):56-63. PubMed ID: 19875196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: observations from PROVE IT-TIMI 22.
    Bonaca MP; Morrow DA; Braunwald E; Cannon CP; Jiang S; Breher S; Sabatine MS; Kempf T; Wallentin L; Wollert KC
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):203-10. PubMed ID: 20966402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins in acute coronary syndromes: do the guideline recommendations match the evidence?
    Morrissey RP; Diamond GA; Kaul S
    J Am Coll Cardiol; 2009 Oct; 54(15):1425-33. PubMed ID: 19796735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of randomized trials of glycoprotein IIb/IIIa inhibitors in high-risk acute coronary syndromes patients undergoing invasive strategy.
    De Luca G; Navarese EP; Cassetti E; Verdoia M; Suryapranata H
    Am J Cardiol; 2011 Jan; 107(2):198-203. PubMed ID: 21211597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
    Hennekens CH; Schneider WR
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.